Rating: HOLD
| Metric | Value |
|---|---|
| Current Price | $85 |
| Triangulated Fair Value | $74 |
| 12-mo Scenario PWEV | $82 |
| Implied Return | -13% |
| Forward P/E | 23.7x |
| Market Cap | $56B |
| 52-Week Range | $60 – $85 |
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
Investment Thesis
The bull case — 'Bull — Cycle + Re-Rate' (8% weight) — targets $139, +64% vs spot. It needs the multiple to hold or expand.
The dashboard below is the whole argument on one page: spot ($85) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural case — 'Structural — Seed/Trait Pricing Erosion' (20%) — targets $36, -57% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.
Key Debate
P/E Multiple explains 48% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.32 vs analyst floor +0.00 → delta +0.32 (n=25 mgmt / 13 Q&A; 37th pctile across the S&P book, z -0.5).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.32 | +0.00 | +0.32 |
| 2025Q4 | +0.39 | +0.12 | +0.27 |
| 2025Q3 | +0.32 | +0.02 | +0.30 |
| 2025Q2 | +0.38 | +0.18 | +0.20 |
News (last 365d, 1000 articles): avg ticker sentiment +0.21 (bullish 27% / bearish 2%)
Scenario Analysis
The tree runs from a structural 'Structural — Seed/Trait Pricing Erosion' downside ($36) to a 'Bull — Cycle + Re-Rate' bull case ($139); the probability-weighted blend (PWEV $82) is -3% versus spot.
| Scenario | Probability | Target | Return |
|---|---|---|---|
| Structural — Seed/Trait Pricing Erosion | 20% | $36 | -57% |
| Downturn — Farm-Income Slump | 18% | $64 | -24% |
| Base — Seed + Crop-Protection Growth | 33% | $87 | +3% |
| Growth — Biologicals / New Traits | 21% | $113 | +34% |
| Bull — Cycle + Re-Rate | 8% | $139 | +64% |
| Probability-Weighted (PWEV) | — | $82 | -3% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Seed/Trait Pricing Erosion (20%, $36). Structural impairment — farm-income downturn: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 36.23; probability: 0.2.
- Downturn — Farm-Income Slump (18%, $64). Cyclical downturn — global farm income + seed/trait pricing + crop-protection demand weakens for 1–2 years before normalising. Drivers — implied_target: 64.1; probability: 0.18.
- Base — Seed + Crop-Protection Growth (33%, $87). Mid-cycle — normalised global farm income + seed/trait pricing + crop-protection demand; disciplined capital allocation; steady returns. Drivers — implied_target: 86.86; probability: 0.33.
- Growth — Biologicals / New Traits (21%, $113). Upside — biologicals + trait upgrades lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 113.38; probability: 0.21.
- Bull — Cycle + Re-Rate (8%, $139). Upside tail — sustained tight conditions or a structural re-rate on biologicals + trait upgrades. Drivers — implied_target: 138.54; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $73 | -14% |
| Peer P/E re-rate | multiple | $64 | -24% |
| Peer EV/Revenue re-rate | multiple | $55 | -35% |
| Scenario PWEV | multiple | $82 | -3% |
| DCF (5-year + terminal) | cash flow + terminal × | $71 | -16% |
| Triangulated (weighted) | — | $74 | -13% |
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $73 and 37% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (48% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 8.5%, 20x terminal FCF multiple → $71. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 17.865000000000002x) implies $64. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is tight (the methods corroborate one another).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|
| Seed + Crop Protection | $17.9B | 100% | 5% | 16% | 23x | 5% | ESTIMATE |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | global farm income + seed/trait pricing + crop-protection demand |
| net_debt_or_cash_b | -1.22 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.05 |
| div_yield | 0.0091 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | farm-income downturn |
| upside | biologicals + trait upgrades |
Industry Context — Materials — Quality
This name sits in the Materials — Quality as a ag_specialty. global farm income + seed/trait pricing + crop-protection demand Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: LIN (gases) · SHW (coatings) · ECL (coatings) · APD (gases) · CTVA (ag_specialty) · PPG (coatings) · IFF (coatings) · DD (coatings)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Industrial Recession — Demand / De-Rate | 38% | 38% | |
| Mid-Cycle — Steady Compounding | 33% | 33% | |
| Expansion — Volume + Pricing Upside | 29% | 29% |
On the cluster's key downside — Industrial Recession — Demand / De-Rate () — this name implies 38% vs the cluster house view of 38% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The quality cycle is the shared macro driver. Driver — global industrial demand + pricing power (gases, coatings, specialty/ag) Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $19B | $3B | $1B | $1B | $2B | $2B |
| FY+2 | $20B | $3B | $1B | $1B | $2B | $2B |
| FY+3 | $21B | $3B | $1B | $1B | $3B | $2B |
| FY+4 | $21B | $4B | $1B | $1B | $3B | $2B |
| FY+5 | $22B | $4B | $1B | $1B | $3B | $2B |
| Terminal | — | — | — | — | $3B × 20x | $38B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 5% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 8.5% · Σ PV(FCF) $10B + PV(terminal) $38B = EV $48B; + net cash → equity $47B ÷ diluted shares 0.66B = $71/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $63/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 11% vs WACC 8% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| CF | 2.351x | 5.94x | 2% | 34% |
| MOS | 0.997x | 22.27x | 2% | 1% |
| NUE | 1.795x | 16.05x | 2% | 12% |
| APD | 6.4x | 19.68x | 6% | 24% |
| Median | 2.073x | 17.865000000000002x | — | — |
Peer-median fwd P/E → $64; EV/Rev → $55.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $71 | 41% | $29 |
| Scenario PWEV | $82 | 29% | $24 |
| Monte Carlo median | $73 | 18% | $13 |
| Peer P/E | $64 | 12% | $8 |
| Triangulated | — | 100% | $74 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC ＼ Term× | 14.0x | 17.0x | 20.0x | 23.0x | 26.0x |
|---|---|---|---|---|---|
| 6% | $59 | $68 | $77 | $87 | $96 |
| 8% | $56 | $65 | $74 | $83 | $92 |
| 8% | $54 | $62 | $71 | $80 | $88 |
| 10% | $52 | $60 | $68 | $76 | $84 |
| 10% | $50 | $57 | $65 | $73 | $81 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ ＼ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $52 | $58 | $63 | $69 | $75 |
| -1.5pp | $55 | $61 | $67 | $73 | $80 |
| +0.0pp | $58 | $64 | $71 | $78 | $84 |
| +1.5pp | $61 | $68 | $75 | $82 | $89 |
| +3.0pp | $64 | $72 | $79 | $87 | $95 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $58 | $84 | $27 |
| Terminal × ±15% | $62 | $80 | $17 |
| Revenue CAGR ±3pp | $63 | $79 | $16 |
| WACC ±1pp | $68 | $74 | $6 |
| FCF conversion ±10% | $71 | $71 | $0 |
Company lever — SoP/share vs Seed + Crop Protection multiple (AI re-rating) (base 23x)
| Multiple | 16.1x | 19.6x | 23.0x | 26.4x | 29.9x |
|---|---|---|---|---|---|
| SoP/share | $437 | $533 | $626 | $719 | $814 |
Load-Bearing Assumptions
DCF: WACC 8%, terminal multiple 20×, FY+5 revenue $22B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
The valuation is multiple-dependent (48% of variance); a de-rating toward the DCF anchor ($71) implies -16%.
Fact / Inference / Speculation
- FACT: Spot $85; 52-week range $60–$85; engine rating HOLD; base-case target $82 (-3%).
- INFERENCE: Triangulated FV $74 (-13%). P/E Multiple explains 48% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
- SPECULATION: At current prices the embedded bet is that the multiple holds or expands — P/E Multiple carries 48% of outcome variance.
Recommendation: HOLD
Balanced: triangulated fair value $74 (-13% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple (48% of variance) — fundamentally a multiple/regime call. SBC runs —M TTM (disclosed in the appendix).